Literature DB >> 21467840

The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells.

Hongxia Li1, Quanli Gao, Liping Guo, Shih Hsin Lu.   

Abstract

Recent reports have shown that cancer stem cells exist in many malignancies. Side population (SP) cells are used to enrich cancer stem-like cells in many cell lines and fresh tumor specimens. In this study, we cultured primary esophageal squamous cell carcinoma (ESCC) cells from ESCC tissue specimens. SP cells from primary ESCC cells were more resistant to chemotherapeutic reagents and formed more colonies in vitro than non-SP cells. In addition, xenograft experiments revealed that SP cells were more tumorigenic in vivo. Further results indicated that the PI3K/Akt pathway is essential to SP cells through the regulation of ABCG2 transporter function. Furthermore, PTEN, rather than mTOR, was found to be involved in SP cell regulation in primary ESCC cells. These findings reveal that SP cells are enriched for cancer stem-like cells in primary ESCC cells and that the PTEN/PI3K/Akt pathway regulates this stem-like population. This study indicates that SP cells in primary culture cells from tissue specimens could be a promising model for cancer stem cell research and may help researchers develop novel therapeutic strategies or efficient drugs that target ESCC stem-like cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467840     DOI: 10.4161/cbt.11.11.15531

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  36 in total

1.  Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133+ Skin Cancer Stem Cells.

Authors:  Zhong Chen; Carter Van Waes; Xin Xin Quan; Nga Voong Hawk; Weiping Chen; Jamie Coupar; Steven K Lee; David W Petersen; Paul S Meltzer; Andrew Montemarano; Martin Braun
Journal:  Mol Cancer Ther       Date:  2018-06-29       Impact factor: 6.261

2.  Inhibition of heat shock protein 90 suppresses squamous carcinogenic progression in a mouse model of esophageal cancer.

Authors:  Shaoxiang Wang; Zhan Du; Jie Luo; Xiao Wang; Haiying Li; Yuting Liu; Yong Zhang; Jiwei Ma; Weiwei Xiao; Yifei Wang; Xueyun Zhong
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-07       Impact factor: 4.553

Review 3.  Rapalogs in cancer prevention: anti-aging or anticancer?

Authors:  Mikhail V Blagosklonny
Journal:  Cancer Biol Ther       Date:  2012-11-14       Impact factor: 4.742

4.  RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway.

Authors:  Hui Zhao; Jianping Yang; Tianli Fan; Shenglei Li; Xuequn Ren
Journal:  Tumour Biol       Date:  2012-04-03

5.  Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.

Authors:  Ren-Chin Wu; Ayse Ayhan; Daichi Maeda; Kyu-Rae Kim; Blaise A Clarke; Patricia Shaw; Michael Herman Chui; Barry Rosen; Ie-Ming Shih; Tian-Li Wang
Journal:  J Pathol       Date:  2014-03       Impact factor: 7.996

6.  Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway.

Authors:  P-P Liu; J Liao; Z-J Tang; W-J Wu; J Yang; Z-L Zeng; Y Hu; P Wang; H-Q Ju; R-H Xu; P Huang
Journal:  Cell Death Differ       Date:  2013-10-04       Impact factor: 15.828

7.  Association of PYGO2 and EGFR in esophageal squamous cell carcinoma.

Authors:  Meysam Moghbeli; Mohammad Reza Abbaszadegan; Moein Farshchian; Mehdi Montazer; Reza Raeisossadati; Abbas Abdollahi; Mohammad Mahdi Forghanifard
Journal:  Med Oncol       Date:  2013-03-03       Impact factor: 3.064

Review 8.  Circular RNAs and their participation in stemness of cancer.

Authors:  Francisco Alejandro Lagunas-Rangel
Journal:  Med Oncol       Date:  2020-04-07       Impact factor: 3.064

9.  Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery.

Authors:  Tong Zhu; Qiuxing Yang; Jingjing Shao; Zhuolin Chen; Bo Cai; Guoxin Mao
Journal:  Virchows Arch       Date:  2021-07-27       Impact factor: 4.064

Review 10.  Stem-like cells and therapy resistance in squamous cell carcinomas.

Authors:  Nicole Facompre; Hiroshi Nakagawa; Meenhard Herlyn; Devraj Basu
Journal:  Adv Pharmacol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.